window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : August 18, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

AI in Healthcare

  • Central Nervous System,Genomics and sequencing,Research & Development,Therapeutic Areas

    Alamar expands Alzheimer’s proteomics partnership with 86,000 more samples

    Alamar Biosciences is expanding a partnership with the Alzheimer’s Disease [...]

    August 12, 2026
  • Digital & Data,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    AI model cuts radiopharmaceutical dose mapping to seconds in prostate cancer study

    A new AI model has generated patient-specific radiation dose-rate maps [...]

    August 5, 2026
  • Clinical & Regulatory,Digital & Data,Medical devices

    ThinkSono wins FDA clearance for AI-guided ultrasound software for suspected DVT

    ThinkSono has received US FDA 510(k) clearance for ThinkSono Guidance, [...]

    July 31, 2026
  • Central Nervous System,Digital & Data,Medical devices

    Natus expands AI-powered EEG analysis across Europe

    Natus has expanded access to its AI-powered EEG analysis tool [...]

    July 22, 2026
  • Biotech & Pharma Business,Digital & Data,Pharmaceuticals and therapeutics

    Outcome Capital launches advisory board to advance innovation in pharmacy and related services

    Outcome Capital, a life sciences and healthcare advisory and investment [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data

    myTomorrows secures $29 million from Avego to expand global access to pre-approval treatments

    myTomorrows has raised $29 million from Avego to support its [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Opinion & Events,Pharmaceuticals and therapeutics

    QuantHealth secures strategic investment from Sanofi Ventures to accelerate AI-driven clinical trials

    QuantHealth, a pioneer in AI-driven clinical trial simulation, has received [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Opinion & Events,Pharmaceuticals and therapeutics

    M42 partners with Medical Tourism Association and Mastercard to expand UAE’s global patient reach

    M42, a global health leader leveraging artificial intelligence, technology, and [...]

    May 5, 2026
  • Digital & Data,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Gifthealth streamlines patient access with AI-driven pharmacy logistics and direct-to-patient model

    As supply chain pressures and rising drug costs challenge patients [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Lithuania’s vice minister Daniel Naumovas on health innovation: “We want patients to feel they can get the best treatment here”

    Daniel Naumovas is a scientist, a teacher and, at 31, [...]

    May 5, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • CN Bio wins Innovate UK grant to develop human-relevant drug testing workflow
    Categories: Digital & Data, Drug Discovery & Development, Manufacturing & Supply Chain, Research & Development
  • FDA grants Priority Review to Belite Bio’s tinlarebant for Stargardt disease
    Categories: Clinical & Regulatory, Drug Delivery & Formulation, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Skylark Bio doses first patient in Phase 1/2 trial for GJB2-related deafness
    Categories: Advanced Therapies, Clinical & Regulatory, Genomics and sequencing, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top